Pondel, K., Kawałko, K., Bielewicz, K., Chmura, A., & Karaś, A. (2022). Effect of glucagon-like peptide-1 (GLP-1) agonists on the example of semaglutide on the cardiovascular system and their role in the treatment of obesity. Journal of Education, Health and Sport, 12(9), 55–60. https://doi.org/10.12775/JEHS.2022.12.09.007